Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands

Anna Miquel-Cases, Lotte M.G. Steuten, Lisanne S. Rigter, Wim H. van Harten* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
58 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands'. Together they form a unique fingerprint.

Medicine & Life Sciences